journal article·2018-05-16Open access

Controlling the Growth of Staphylococcus epidermidis by Layer-By-Layer Encapsulation

Alain M. Jonas, Karine Glinel, Adam Behrens, Aaron C. Anselmo, Robert S. Langer, Ana Jaklenec

ACS Applied Materials & Interfaces· Volume 10· Issue 19

Abstract

Commensal skin bacteria such as Staphylococcus epidermidis are currently being considered as possible components in skin-care and skin-health products. However, considering the potentially adverse effects of commensal skin bacteria if left free to proliferate, it is crucial to develop methodologies that are capable of maintaining bacteria viability while controlling their proliferation. Here, we encapsulate S. epidermidis in shells of increasing thickness using layer-by-layer assembly, with either a pair of synthetic polyelectrolytes or a pair of oppositely charged polysaccharides. We study the viability of the cells and their delay of growth depending on the composition of the shell, its thickness, the charge of the last deposited layer, and the degree of aggregation of the bacteria which is varied using different coating procedures-among which is a new scalable process that easily leads to large amounts of nonaggregated bacteria. We demonstrate that the growth of bacteria is not controlled by the mechanical properties of the shell but by the bacteriostatic effect of the polyelectrolyte complex, which depends on the shell thickness and charge of its outmost layer, and involves the diffusion of unpaired amine sites through the shell. The lag times of growth are sufficient to prevent proliferation for daily topical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Nail Diseases and Treatments · Dermatology and Skin Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Condensed Matter and Nanosciences, Université catholique de Louvain, Croix du Sud 1/L7.04.02, Louvain-la-Neuve 1348, Belgium

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main Street, Cambridge, Massachusetts 02139, United States

Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

Funding

Fulbright Association · Fondation Louvain · Fonds De La Recherche Scientifique - FNRS · Wallonia-Brussels International

References (71)

Show source-provided references
1. Döderlein A. · 1892
2. 10.1016/j.cell.2014.03.01110.1016/j.cell.2014.03.011 ↗
3. 10.1002/adma.20160327010.1002/adma.201603270 ↗
4. 10.1016/j.jfoodeng.2014.03.01510.1016/j.jfoodeng.2014.03.015 ↗
5. Prakash K. S. · 2016 · 3310.1007/978-81-322-2610-9_3 ↗
6. 10.1021/jf203378s10.1021/jf203378s ↗
7. Michael T. M. · 2015
8. 10.1038/nature0907410.1038/nature09074 ↗
9. 10.1016/j.jid.2015.12.02410.1016/j.jid.2015.12.024 ↗
10. 10.1038/jid.2009.24310.1038/jid.2009.243 ↗
11. 10.1038/srep2787010.1038/srep27870 ↗
12. 10.1007/s00281-014-0452-610.1007/s00281-014-0452-6 ↗
13. 10.1016/j.ijmm.2014.04.01310.1016/j.ijmm.2014.04.013 ↗
14. 10.1007/s00005-015-0332-310.1007/s00005-015-0332-3 ↗
15. 10.1016/j.ijmm.2010.04.01110.1016/j.ijmm.2010.04.011 ↗
16. 10.1038/nrmicro218210.1038/nrmicro2182 ↗
17. 10.1007/s11882-015-0567-410.1007/s11882-015-0567-4 ↗
18. 10.1126/science.117170010.1126/science.1171700 ↗
19. 10.1021/cen-09519-cover10.1021/cen-09519-cover ↗
20. 10.1111/j.1574-6976.2009.00200.x10.1111/j.1574-6976.2009.00200.x ↗
21. 10.1016/j.mimet.2014.04.01210.1016/j.mimet.2014.04.012 ↗
22. 10.1039/c2cs15264a10.1039/c2cs15264a ↗
23. 10.1021/nn301776y10.1021/nn301776y ↗
24. 10.1002/adma.20130456810.1002/adma.201304568 ↗
25. Wang B. · 2014 · 410.1039/9781782628477-00004 ↗
26. Hong D. · 2014 · 14210.1039/9781782628477-00142 ↗
27. Park J. H. · 2014 · 4810.1039/9781782628477-00048 ↗
28. 10.1166/jnn.2014.910610.1166/jnn.2014.9106 ↗
29. 10.1021/acs.accounts.6b0008710.1021/acs.accounts.6b00087 ↗
30. 10.1002/asia.20160014510.1002/asia.201600145 ↗
31. 10.1002/adfm.20150448010.1002/adfm.201504480 ↗
32. 10.1021/la900971h10.1021/la900971h ↗
33. 10.1002/jbm.a.3493610.1002/jbm.a.34936 ↗
34. 10.4172/2157-7439.100015210.4172/2157-7439.1000152 ↗
35. 10.1002/mabi.20090014210.1002/mabi.200900142 ↗
36. 10.1039/c0cc00468e10.1039/c0cc00468e ↗
37. 10.1021/la301451410.1021/la3014514 ↗
38. 10.1039/c3nr03905f10.1039/c3nr03905f ↗
39. 10.1021/bm301636210.1021/bm3016362 ↗
40. 10.1021/acsnano.5b0113910.1021/acsnano.5b01139 ↗
41. 10.1002/anie.20141204910.1002/anie.201412049 ↗
42. 10.1039/c4sc02638a10.1039/c4sc02638a ↗
43. 10.1002/adma.20160233510.1002/adma.201602335 ↗
44. 10.1002/anie.20110203010.1002/anie.201102030 ↗
45. 10.1002/asia.20140299310.1002/asia.201402993 ↗
46. 10.1039/c4cc08544b10.1039/c4cc08544b ↗
47. 10.1039/c4sc02789b10.1039/c4sc02789b ↗
48. 10.1021/la901395z10.1021/la901395z ↗
49. 10.1002/anie.20070471810.1002/anie.200704718 ↗
50. 10.1039/b808871c10.1039/b808871c ↗
51. 10.1021/la025646e10.1021/la025646e ↗
52. 10.1021/bm101200c10.1021/bm101200c ↗
53. 10.1021/ja110926s10.1021/ja110926s ↗
54. 10.1021/nn300835510.1021/nn3008355 ↗
55. 10.1039/c2cc38254g10.1039/c2cc38254g ↗
56. 10.1002/marc.20130044410.1002/marc.201300444 ↗
57. 10.1021/ja110018910.1021/ja1100189 ↗
58. 10.1039/c0sm01070g10.1039/c0sm01070g ↗
59. 10.1039/c5nr05573c10.1039/c5nr05573c ↗
60. 10.1021/acs.macromol.6b0244510.1021/acs.macromol.6b02445 ↗
61. 10.1021/ma050795010.1021/ma0507950 ↗
62. 10.1021/acs.langmuir.5b0247810.1021/acs.langmuir.5b02478 ↗
63. 10.1021/acs.langmuir.6b0049910.1021/acs.langmuir.6b00499 ↗
64. 10.1021/ie990092510.1021/ie9900925 ↗
65. 10.1002/adma.20130269610.1002/adma.201302696 ↗
66. 10.1007/s10811-007-9229-910.1007/s10811-007-9229-9 ↗
67. 10.1021/ma070325110.1021/ma0703251 ↗
68. 10.1021/la903121e10.1021/la903121e ↗
69. 10.1021/jacs.7b0790510.1021/jacs.7b07905 ↗
70. 10.1021/nl052121910.1021/nl0521219 ↗
71. 10.1021/la990650k10.1021/la990650k ↗